Cycle view
- Bloc
- Organization
- Theory
- Practical
- Others
- Credits
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR0344-3 | Medicine analysis - [10h Seminar] | B1 | Q1 | 36 | 28 | [+] | 7 |
| PHAR0343-3 | Pharmaceutical technologies and biopharmacy (part I) | B1 | Q1 | 20 | 60 | - | 4 |
| PHAC0341-2 | Special pharmacology (Part I) | B1 | Q1 | 25 | - | - | 3 |
| TOXI0341-2 | Toxiocological chemistry, Part I | B1 | Q1 | 4 | |||
| Toxiocological chemistry | 25 | - | - | ||||
| Toxicological chemistry, supplement for pharmacy - [12h Seminar] | - | - | [+] | ||||
| BIOC0340-1 | Clinical Chemistry (Part I) - [12h Seminar] | B1 | Q1 | 22 | - | [+] | 4 |
| MBIO0002-1 | Pharmaceutical Microbiology | B1 | Q1 | 16 | - | - | 2 |
| PHAR2018-1 | Good officinal pharmaceutical practice - [6h Seminar] | B1 | Q1 | 10 | - | [+] | 2 |
| ECON0340-1 | Pharmacoeconomy | B1 | Q1 | 10 | - | - | 1 |
| PHAR0003-1
| Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| PHAR0347-3 | Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
| B1 | Q2 | - | 32 | - | 2 |
| PHAC0342-2 | Special pharmacology (Part II)
Corequisite
| B1 | Q2 | 20 | - | - | 2 |
| TOXI0342-2 | Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| BIOC0341-1 | Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
| B1 | Q2 | 23 | - | [+] | 4 |
| PHAR0004-1 | Pharamcotherapy and pharmaceutical cares - [10h Seminar] | B1 | Q2 | 30 | - | [+] | 4 |
| SANT0005-1 | Therapeutic approach - [20h Séminaire Interdisciplinaire] | B1 | Q2 | - | - | [+] | 2 |
| LEGI0340-2 | Legislation and pharmaceutical ethics | B1 | Q2 | 30 | - | - | 3 |
| PHAR2121-1 | Practical integrated work
Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Anna Lechanteur, Allison Ledoux, Géraldine Piel, Anne-Catherine Servais, Eric Ziemons
Corequisite
| B1 | Q2 | - | 32 | - | 2 |
| PHAR2226-1 | Innovative therapy medications | B1 | Q2 | 10 | - | - | 1 |
| APPR1003-1 | Interdisciplinarity and vaccination | B2 | Q2 | 1 | |||
| Interdisciplinarity - [12h Seminar] | 2 | 2 | [+] | ||||
| Vaccination - [8h Seminar]
Corequisite
| - | - | [+] | ||||
| PHAR0721-1 | Incorporation of pharmaceutical knowledge
Etienne Cavalier, Corinne Charlier, Robin Crunenberg, Raphaël Denooz, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Julien Hanson, Patrick Herné, Frédéric Lecomte, Caroline Le Goff, Geneviève Philippe, Géraldine Piel, Bernard Pirotte, Anne-Catherine Servais, Vincent Seutin
Corequisite
| B2 | Q2 | - | - | - | 5 |
Compulsory Training |
|||||||
| MTFE0351-3 | Officinal internship, thesis, and industrial visits | B2 | TA | 29 | |||
| Learning file and participation in the clinical research project - [100h Personal research] | - | - | [+] | ||||
| Officinal internship - [6mois internship] | - | - | [+] | ||||
| Industrial visits - [120h Visit]
Prerequisite
Corequisite
| - | - | [+] | ||||
| Notice : students must do a placement in a pharmacy of a legal duration of six months (26 weeks), and compile a learning record (dissertation) at the same time. This placement includes a compulsory introductory two-week internship, during the summer, after the bachelor's degree. For students who have acquired a minimum of 45 ECTS from block 1 of the master's degree, they can do their placement in a pharmacy during the summer holidays before starting block 2 of the master's degree (maximum 8 weeks). The remaining number of weeks (minimum 16 weeks) can be done within the framework of block 2 of the master's (2nd term). | |||||||
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR2228-1 | Specific courses for the professional focus in drug design and development - bioanalysis (Term 2) | B1 | Q2 | 5 | |||
| Natural-source raw materials | - | 20 | - | ||||
| Analysis of biological medicinal products and medicinal products in biofluids | 10 | - | - | ||||
| Drug design | 10 | - | - | ||||
| Industrial pharmaceutical technology | 10 | - | - | ||||
| Sterilisation methods
Aurore Napp, Isabelle Roland, Gaëtan Van Haren
| 10 | - | - | ||||
| PHAR2230-1 | Specific courses for the professional focus in conception and development of medicine - bioanalysis (Term 1) | B2 | Q1 | 5 | |||
| Quality in the pharmaceutical industry and regulatory affairs | 10 | - | - | ||||
| Specific concepts in clinical biology | 10 | - | - | ||||
| Additional topics in pharmacokinetics | 10 | - | - | ||||
| Critical analysis of clinical studies | 10 | - | - | ||||
| Radiopharmacy
Pierre Francotte, Mallory Salvé, Frédéric Schmitz
| 10 | - | - | ||||
| PHAR2234-1 | Pharmaceutical integration seminars on finished products - [30h Séminaire Interdisciplinaire]
Corinne Charlier, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Anna Lechanteur, Allison Ledoux, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Vincent Seutin, Eric Ziemons
Prerequisite
| B2 | Q2 | - | - | [+] | 5 |
Focus optional courses
- B2
- 15Cr
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||